BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7746172)

  • 21. Screening for gynecologic cancer. Vulvar, vaginal, endometrial, and ovarian neoplasms.
    Hall KL; Dewar MA; Perchalski J
    Prim Care; 1992 Sep; 19(3):607-20. PubMed ID: 1410066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is routine adnexal scanning for postmenopausal bleeding of value? Observational study of 2101 women.
    Bakour S; Emovon E; Nevin J; Ewies AAA
    J Obstet Gynaecol; 2017 Aug; 37(6):779-782. PubMed ID: 28485195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conservative management of postmenopausal pelvic echo-free findings--preliminary results.
    Pardo J; Kaplan B; Levavi H; Nitke S; Mashiach R; Neri A
    Maturitas; 1996 Apr; 23(3):279-83. PubMed ID: 8794421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The value of MR imaging in distinguishing leiomyomas from other solid pelvic masses when sonography is indeterminate.
    Weinreb JC; Barkoff ND; Megibow A; Demopoulos R
    AJR Am J Roentgenol; 1990 Feb; 154(2):295-9. PubMed ID: 2105017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for ovarian cancer: a pilot randomised controlled trial.
    Jacobs IJ; Skates SJ; MacDonald N; Menon U; Rosenthal AN; Davies AP; Woolas R; Jeyarajah AR; Sibley K; Lowe DG; Oram DH
    Lancet; 1999 Apr; 353(9160):1207-10. PubMed ID: 10217079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population screening and early detection of ovarian cancer in asymptomatic women.
    Nelson AE; Francis JE; Zorbas H;
    Aust N Z J Obstet Gynaecol; 2009 Oct; 49(5):448-50. PubMed ID: 19780723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uterine leiomyoma with associated pseudo-Meigs syndrome mimicking ovarian carcinoma.
    Landrum LM; Rutledge TL; Osunkoya AO; Mannel R
    J Okla State Med Assoc; 2008 Feb; 101(2):38-9. PubMed ID: 18361033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum CA-125 in relation to adnexal dysplasia and cancer in women at hereditary high risk of ovarian cancer.
    Hermsen BB; von Mensdorff-Pouilly S; Berkhof J; van Diest PJ; Gille JJ; Menko FH; Blankenstein MA; Kenemans P; Verheijen RH
    J Clin Oncol; 2007 Apr; 25(11):1383-9. PubMed ID: 17416858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ovarian cancer screening in asymptomatic postmenopausal women by transvaginal sonography.
    Van Nagell JR; DePriest PD; Puls LE; Donaldson ES; Gallion HH; Pavlik EJ; Powell DE; Kryscio RJ
    Cancer; 1991 Aug; 68(3):458-62. PubMed ID: 2065264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pelvic masses and endoscopic surgery: diagnosis.
    Miralles RM
    Eur J Obstet Gynecol Reprod Biol; 1996 Mar; 65(1):75-9. PubMed ID: 8706963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NIH Consensus 1994: screening.
    Kramer BS; Gohagan J; Prorok PC
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S20-1. PubMed ID: 7835804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of laparoscopy in the diagnosis and treatment of adnexal masses.
    Leng JH; Lang JH; Zhang JJ; Feng FZ; Liu ZF; Sun DW; Zhu L; Zhao XY
    Chin Med J (Engl); 2006 Feb; 119(3):202-6. PubMed ID: 16537005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leiomyoma of broad ligament mimicking ovarian malignancy- report of a unique case.
    Mallick D; Saha M; Chakrabarti S; Chakraborty J
    Kathmandu Univ Med J (KUMJ); 2014; 12(47):219-21. PubMed ID: 25855117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transvaginal sonography as a screening method for the detection of early ovarian cancer.
    DePriest PD; Gallion HH; Pavlik EJ; Kryscio RJ; van Nagell JR
    Gynecol Oncol; 1997 Jun; 65(3):408-14. PubMed ID: 9190966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are too many imaging tests being performed in women with an adnexal mass?
    Kupets R; Fernandes K; Miroshnichenko G; Paszat L
    J Obstet Gynaecol Can; 2013 Mar; 35(3):246-251. PubMed ID: 23470112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography.
    Jacobs I; Davies AP; Bridges J; Stabile I; Fay T; Lower A; Grudzinskas JG; Oram D
    BMJ; 1993 Apr; 306(6884):1030-4. PubMed ID: 8490497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laparoscopic findings during adnexal surgery in women with a history of nongynecologic malignancy.
    Juretzka MM; Crawford CL; Lee C; Wilton A; Schuman S; Chi DS; Sonoda Y; Barakat RR; Abu-Rustum NR
    Gynecol Oncol; 2006 May; 101(2):327-30. PubMed ID: 16360202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of pelvic ultrasound and magnetic resonance imaging as diagnostic studies for müllerian tract abnormalities.
    Letterie GS; Haggerty M; Lindee G
    Int J Fertil Menopausal Stud; 1995; 40(1):34-8. PubMed ID: 7749433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for ovarian cancer.
    Anderiesz C; Quinn MA
    Med J Aust; 2003 Jun; 178(12):655-6. PubMed ID: 12797860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accuracy of bimanual palpation versus vaginosonography in determination of the measurements of pelvic tumors.
    Popp LW; Gaetje R; Stoyanov M
    Arch Gynecol Obstet; 1993; 252(4):197-202. PubMed ID: 8512349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.